Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Flower-like CoNi-LDH/PtNPs composites for highly efficient electrochemical sensing of methyl parathion in vegetables.

Food chemistry·2026
Same author

Correction: Zi et al. Danusertib Induces Apoptosis, Cell Cycle Arrest, and Autophagy but Inhibits Epithelial to Mesenchymal Transition Involving PI3K/Akt/mTOR Signaling Pathway in Human Ovarian Cancer Cells. <i>Int. J. Mol. Sci.</i> 2015, <i>16</i>, 27228-27251.

International journal of molecular sciences·2026
Same author

Cajanine alleviates anxiety and fear extinction deficits in female mice exposed to single prolonged stress via the ERβ/NF-κB pathway.

Brain research·2026
Same author

Identifying key determinants of cumulative live birth in women with ovarian endometrioma undergoing ethanol sclerotherapy followed by <i>in vitro</i> fertilization or intracytoplasmic sperm injection: an interpretable machine learning analysis.

Frontiers in cell and developmental biology·2026
Same author

Explainable Dynamic Graph Learning and Multi-Scale Feature Fusion for Hydraulic System Health Monitoring.

Sensors (Basel, Switzerland)·2026
Same author

Liquid Bismuth Catalyst Enables High-CO-Selectivity in CO<sub>2</sub> Hydrogenation.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Related Experiment Video

Updated: Jun 26, 2025

Generation of Scalable, Metallic High-Aspect Ratio Nanocomposites in a Biological Liquid Medium
13:34

Generation of Scalable, Metallic High-Aspect Ratio Nanocomposites in a Biological Liquid Medium

Published on: July 8, 2015

9.1K

Biocompatible Copper-Based Nanocomposites for Combined Cancer Therapy.

Yibo Song1, Kok Bing Tan1, Shu-Feng Zhou1

  • 1College of Chemical Engineering, Academy of Advanced Carbon Conversion Technology, Huaqiao University, 668 Jimei Avenue, Xiamen, 361021 Fujian, P. R. China.

ACS Biomaterials Science & Engineering
|May 8, 2024
PubMed
Summary

Copper (Cu) and Cu-based nanomaterials show promise for cancer treatment. This review explores integrated Cu-nanocomplexes for combined therapies, discussing challenges and future clinical translation.

Keywords:
CuMOFscombined cancer therapyintegrated nanomaterialsnanocomposites

More Related Videos

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

6.5K
Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

10.9K

Related Experiment Videos

Last Updated: Jun 26, 2025

Generation of Scalable, Metallic High-Aspect Ratio Nanocomposites in a Biological Liquid Medium
13:34

Generation of Scalable, Metallic High-Aspect Ratio Nanocomposites in a Biological Liquid Medium

Published on: July 8, 2015

9.1K
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

6.5K
Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

10.9K

Area of Science:

  • Nanomedicine and Materials Science
  • Oncology and Cancer Therapeutics

Background:

  • Copper (Cu) and Cu-based nanomaterials possess unique physicochemical properties and biocompatibility, making them attractive for disease treatment, particularly cancer.
  • Existing research has developed diverse Cu-based nanocomplexes for various cancer therapies, including chemotherapy, radiotherapy (RT), photothermal therapy (PTT), chemodynamic therapy (CDT), photodynamic therapy (PDT), and cuproptosis-mediated therapy.

Purpose of the Study:

  • To review the current research landscape of Cu-based nanomaterials in cancer therapy.
  • To discuss the application of Cu-based nanocomplexes in combined cancer treatment strategies.
  • To identify current challenges and future prospects for the clinical translation of these nanotherapeutic platforms.

Main Methods:

  • Comprehensive literature review of studies on Cu-based nanomaterials for cancer therapy.
  • Analysis of integrated Cu-based nanocomplexes and their therapeutic modalities.
  • Discussion of combined therapeutic approaches, including chemotherapy, RT, PTT, CDT, PDT, and cuproptosis.

Main Results:

  • Cu-based nanomaterials offer versatile platforms for developing advanced cancer therapies.
  • Integrated nanocomplexes combining multiple treatment modalities show significant potential for enhanced anticancer efficacy.
  • The development of composite nanosystems is crucial for next-generation nanomedicines.

Conclusions:

  • Cu-based nanocomplexes represent a promising avenue for innovative cancer treatment strategies.
  • Combined therapeutic approaches using these nanocomplexes are essential to overcome the limitations of single treatments.
  • Addressing challenges in clinical translation is key to realizing the full potential of Cu-based nanotherapeutics.